First Time Ever: Artificial Intelligence Nominated As A Board Member!!!!

Some days ago Hong Kong-based Deep Knowledge Ventures appointed for the first time everArtificial Intelligence (A.I.) as an official and equal board member.

Yep! Not a joke! You´re not in Star Treck nor experiencing another sequel of Terminator or an encounter with Optimus Prime and Megatron of The Transformers.

Although robotics and A.I. are already popular in manufacturing, finances, and the military, this marketing stunt makes you wonder, how and when A.I. will further develop and become more and more part of our lives. Scary? Exciting? Both?

In this case A.I. is a sophisticated machine learning program capable of making investment recommendations in the life science sector dubbed VITAL (Validating Investment Tool for Advancing Life Sciences). It basically uses machine learning to analyze financing trends in databases of life science companies and predict successful investments. Aging Analytics, a UK research agency providing life science market, licensed VITAL to Deep Knowledge Ventures. VITAL will report its findings to the board. In addition, it will have an own equal vote in the company´s board when making important investment decisions. The company expects that its opinion will be considered as the most relevant one.

In a press release Deep Knowledge´s senior partner Dmitry Kaminskiy expressed: “The variables involved in the long-term success of a biotechnology company are many and complex. We were attracted to a software tool that could in large part automate due diligence and use historical data-sets to uncover trends that are not immediately obvious to humans surveying top-line data. We plan to incorporate new information from prospective investments into the databases to compare the outcomes against our selected investments.”

So, that sounds more like an algorithm-based software which can quickly and accurately analyze huge quantities of data to identify trends and calculate various business scenarios and options. Aging Analytics claims that its long term goal is to develop VITAL to a point where it can operate “autonomously.” That´s why already now it acts as board member. Fortunately, lacking human intuition and emotions… at least for the time being.

Read  more

Comments are closed.

Leave a Reply

Your email address will not be published. Required fields are marked *